Abstract
Gene therapy is a potential therapeutic strategy for treatment of ischemic vascular diseases; however, the clinical application of gene therapy has met some anticipated challenges. Recent randomized, controlled trials suggest that patients with cardiovascular disease may also benefit from cell-based therapies, and the optimal treatment regimen may combine both approaches to take advantage of potential synergy between the underlying therapeutic mechanisms. This review discusses recent research into both gene and cell therapy and considers the potential application of a combined treatment approach for cardiovascular and cerebrovascular ischemic diseases.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Biological Therapy / methods
-
Brain Ischemia / mortality
-
Brain Ischemia / physiopathology
-
Brain Ischemia / therapy*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / physiopathology
-
Cardiovascular Diseases / therapy
-
Cell- and Tissue-Based Therapy / methods*
-
Combined Modality Therapy
-
Disease Models, Animal
-
Female
-
Genetic Therapy / methods*
-
Humans
-
Male
-
Myocardial Ischemia / mortality
-
Myocardial Ischemia / physiopathology
-
Myocardial Ischemia / therapy*
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Survival Analysis
-
Treatment Outcome